Samsara BioCapital’s Aclaris Therapeutics ACRS Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,385,060	Closed	-$5.91M	–	38
2024 Q4	$5.91M	Buy	2,385,060 +1,688,889	+243%	+$4.19M	0.81%	21
2024 Q3	$801K	Hold	696,171	–	–	0.15%	34
2024 Q2	$766K	Hold	696,171	–	–	0.16%	34
2024 Q1	$863K	Hold	696,171	–	–	0.13%	33
2023 Q4	$731K	Hold	696,171	–	–	0.11%	33
2023 Q3	$4.77M	Hold	696,171	–	–	1.46%	19
2023 Q2	$7.22M	Hold	696,171	–	–	1.27%	15
2023 Q1	$5.63M	Hold	696,171	–	–	1.16%	20
2022 Q4	$11M	Hold	696,171	–	–	2.36%	11
2022 Q3	$11M	Hold	696,171	–	–	2.56%	8
2022 Q2	$9.72M	Sell	696,171 -98,000	-12%	-$1.37M	2.59%	8
2022 Q1	$13.7M	Hold	794,171	–	–	3.45%	10
2021 Q4	$11.5M	Hold	794,171	–	–	2.24%	10
2021 Q3	$14.3M	Hold	794,171	–	–	2.24%	12
2021 Q2	$13.9M	Sell	794,171 -228,441	-22%	-$4.01M	1.72%	12
2021 Q1	$25.8M	Sell	1,022,612 -340,000	-25%	-$8.57M	4.75%	6
2020 Q4	$8.82K	Sell	1,362,612 -790,653	-37%	-$5.12K	0.89%	12
2020 Q3	$5.53M	Sell	2,153,265 -454,852	-17%	-$1.17M	1.54%	16
2020 Q2	$4.23M	Hold	2,608,117	–	–	1.36%	19
2020 Q1	$2.71M	Buy	+2,608,117	New	+$2.71M	1.56%	18